Parisa Meysami
Parisa Meysami
University of Bristol, Bristol, UK
Verified email at
Cited by
Cited by
Prevalence of occult hepatitis C virus infection in Iranian patients with lymphoproliferative disorders
M Farahani, F Bokharaei‐Salim, M Ghane, A Basi, P Meysami, H Keyvani
Journal of medical virology 85 (2), 235-240, 2013
Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles‐and rubella‐like illness in Iran
F Rezaei, B Sarshari, N Ghavami, P Meysami, A Shadab, H Salimi, ...
Journal of medical virology 88 (6), 947-953, 2016
BAP1 status determines the sensitivity of malignant mesothelioma cells to gemcitabine treatment
A Guazzelli, P Meysami, E Bakker, C Demonacos, A Giordano, ...
International journal of molecular sciences 20 (2), 429, 2019
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification
K Tian, E Bakker, M Hussain, A Guazzelli, H Alhebshi, P Meysami, ...
Journal of translational medicine 16 (1), 282, 2018
What can independent research for mesothelioma achieve to treat this orphan disease?
A Guazzelli, P Meysami, E Bakker, E Bonanni, C Demonacos, ...
Expert Opinion on Investigational Drugs, 2019
Antitumor effects of a recombinant baculovirus displaying anti-HER2 scFv expressing Apoptin in HER2 positive SK-BR-3 breast cancer cells
P Meysami, F Rezaei, SM Marashi, MM Amiri, E Bakker, T Mokhtari-Azad
Future Virology 14 (3), 2019
Molecular characterization of hepatitis D virus genotypes circulating in Iran
P Meysami, SM Alavian, SH Monavari, SH Mozhgani, M Taghizadeh, ...
Future Virology 13 (4), 2018
Sirtuin family members selectively regulate autophagy in osteosarcoma and mesothelioma cells in response to cellular stress
R Garva, C Thepmalee, U Yasamut, S Sudsaward, A Guazzelli, ...
The system can't perform the operation now. Try again later.
Articles 1–8